Lobbyist Report for PFIZER INC.

PFIZER INC.

Biopharmaceuticals

1275 Pennsylvania Avenue, NW Suite 600 WASHINGTON, DC 20004

USA

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE HEALTH ISSUES MEDICARE/MEDICAID BUDGET/APPROPRIATIONS COPYRIGHT/PATENT/TRADEMARK TRADE (DOMESTIC/FOREIGN)

Comprehensive Corporate Tax Reform

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements

FY 2020 Appropriation Bills

Creates Act

U.S.- Japan Trade Negotiations U.S.-E.U. Trade Negotiations China Trade Negotiations Canada IP/ Trade Issues APEC OECD NAFTA/USMCA Brazil Trade Chile IP/Trade Argentina PAC-DBIA India Trade Turkey Trade

Lobbyists:

HALLIWELL, JOHN Paul
RIEMER, ANGELA Walker
WALTON, JENNIFER ANNE
Schellhas, CAROLINE Moody
BURG, PAULA
JONES, ROBERT
MUELLER, EMILY
ROBINSON, CATHERINE

ALBEN, ELISSA
Held the following Government positions
Senate Finance Committee
Senior Counsel for Int'l Trade & Competitiveness
USTR General Counsel's Office

Foreign Entities:

Foreign Entity Name:
Bayer AG
Country :
GERMANY
Contribution :
$0

Lobbying on the following issues:

TRADE (DOMESTIC/FOREIGN) BUDGET/APPROPRIATIONS HEALTH ISSUES MEDICARE/MEDICAID COPYRIGHT/PATENT/TRADEMARK TAXATION/INTERNAL REVENUE CODE

FY 2020 Appropriation Bills

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements

Creates Act

Comprehensive Corporate Tax Reform

Lobbyists:

Foreign Entities:

Foreign Entity Name:
Vestas Wind System A/S
Country :
DENMARK
Contribution :
$0

Lobbying on the following issues:

HEALTH ISSUES MEDICARE/MEDICAID TRADE (DOMESTIC/FOREIGN) TAXATION/INTERNAL REVENUE CODE BUDGET/APPROPRIATIONS

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency

U.S.- Japan Trade Negotiations China Trade Negotiations Foreign Market Access Issues NAFTA/USMCA International Supply Chain/Buy America U.S.- U.K. Trade Negotiations U.S. - Kenya FTA

Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation

Congressional Appropriations

Lobbyists:

RIEMER, ANGELA Walker
WALTON, JENNIFER ANNE
Schellhas, CAROLINE Moody
BURG, PAULA
JONES, ROBERT
ROBINSON, CATHERINE
CLAEYS, STEPHEN
ALBEN, ELISSA
MUELLER, EMILY

Knott, Joseph Tucker
Held the following Government positions
Staff Aide
Chief of Staff

Foreign Entities:

Foreign Entity Name:
Block.One
Country :
CAYMAN ISLANDS
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE HEALTH ISSUES COPYRIGHT/PATENT/TRADEMARK MEDICARE/MEDICAID TRADE (DOMESTIC/FOREIGN)

Comprehensive Corporate Tax Reform International Tax Reform

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform

Creates Act

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency

U.S.- Japan Trade Negotiations China Trade Negotiations APEC OECD NAFTA/USMCA Brazil Trade Chile IP/Trade Argentina PAC-DBIA India Trade Turkey Trade

Lobbyists:

Foreign Entities:

Foreign Entity Name :
Philip Morris Brands Sarl (Parent Company is PMI)
Country :
SWITZERLAND
Contribution :
$0
-
Foreign Entity Name :
Philip Morris Products S.A. (Parent Company is PMI)
Country :
SWITZERLAND
Contribution :
$0
-

Lobbying on the following issues:

BUDGET/APPROPRIATIONS COPYRIGHT/PATENT/TRADEMARK ALCOHOL AND DRUG ABUSE HEALTH ISSUES TAXATION/INTERNAL REVENUE CODE MEDICARE/MEDICAID

2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018

Creates Act Transferable exclusivity

Prescription Drug Abuse

Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA

Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act of 2017 (TCJA)

Medicare Part D Coverage Gap

Lobbyists:

HALLIWELL, JOHN Paul
RIEMER, ANGELA Walker
WALTON, JENNIFER ANNE
Schellhas, CAROLINE Moody
BURG, PAULA
JONES, ROBERT

MUELLER, EMILY
Held the following Government positions
Legislative Correspondent
Legislative Assistant
Legislative Director
Senior Health Policy Advisor
Deputy Legislative Director Legislative Correspondent
Deputy Legislative Director

Foreign Entities:

Foreign Entity Name:
ABB Asea Brown Boveri, Ltd.
Country :
SWITZERLAND
Contribution :
$0

Lobbying on the following issues:

HEALTH ISSUES BUDGET/APPROPRIATIONS MEDICARE/MEDICAID TRADE (DOMESTIC/FOREIGN) COPYRIGHT/PATENT/TRADEMARK TAXATION/INTERNAL REVENUE CODE

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform

Health Extenders/Congressional Appropriations

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency

U.S.- Japan Trade Negotiations China Trade Negotiations NAFTA/USMCA Foreign Market Access Issues

Creates Act Patent Thickets/Hopping

Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation

Lobbyists:

RIEMER, ANGELA Walker
WALTON, JENNIFER ANNE
Schellhas, CAROLINE Moody
BURG, PAULA
JONES, ROBERT

Knott, Joseph Tucker
Held the following Government positions
Staff Aide
Chief of Staff Staff Aide
Chief of Staff

ROBINSON, CATHERINE
MUELLER, EMILY
ALBEN, ELISSA

CLAEYS, STEPHEN
Held the following Government positions
Trade Counsel, Committee on Ways & Means
Deputy Asst. Secretary for AD/CVD Ops., Dept. of Commerce
Nat'l Security Advisor, Office of the Vice President, White House
Chief of Staff to Assistant Secretary for Import Administration, Dept. of Commerce

Foreign Entities:

Foreign Entity Name:
Kering
Country :
FRANCE
Contribution :
$0

Lobbying on the following issues:

HEALTH ISSUES MEDICARE/MEDICAID BUDGET/APPROPRIATIONS COPYRIGHT/PATENT/TRADEMARK TAXATION/INTERNAL REVENUE CODE TRADE (DOMESTIC/FOREIGN)

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency

Health Extenders/Congressional Appropriations

Creates Act Patent Thickets/Hopping

Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation

U.S.- Japan Trade Negotiations China Trade Negotiations NAFTA/USMCA Foreign Market Access Issues

Lobbyists:

RIEMER, ANGELA Walker
WALTON, JENNIFER ANNE
Schellhas, CAROLINE Moody
BURG, PAULA
JONES, ROBERT
MUELLER, EMILY

Knott, Joseph Tucker
Held the following Government positions
Staff Aide
Chief of Staff Staff Aide
Chief of Staff

ROBINSON, CATHERINE

CLAEYS, STEPHEN
Held the following Government positions
Trade Counsel, Committee on Ways & Means
Deputy Asst. Secretary for AD/CVD Ops., Dept. of Commerce
Nat'l Security Advisor, Office of the Vice President, White House
Chief of Staff to Assistant Secretary for Import Administration, Dept. of Commerce

ALBEN, ELISSA

Lobbying on the following issues:

TRADE (DOMESTIC/FOREIGN) COPYRIGHT/PATENT/TRADEMARK MEDICARE/MEDICAID TAXATION/INTERNAL REVENUE CODE BUDGET/APPROPRIATIONS HEALTH ISSUES

US-Japan Trade Agreement

Creates Act Transferable exclusivity

Medicare Part D Coverage Gap

Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act of 2017 (TCJA)

2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018

Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA

Lobbyists:

HALLIWELL, JOHN Paul
RIEMER, ANGELA Walker
WALTON, JENNIFER ANNE
Schellhas, CAROLINE Moody
BURG, PAULA

ROBINSON, CATHERINE
Held the following Government positions
Case Manager, U.S. House of Representatives
Law Clerk, Ways and Means Trade Subcommittee

Foreign Entities:

Foreign Entity Name :
ABB Asea Brown Boveri, Ltd.
Country :
SWITZERLAND
Contribution :
$0
-
Foreign Entity Name :
ABB, Ltd.
Country :
SWITZERLAND
Contribution :
$0
-

Lobbying on the following issues:

HEALTH ISSUES MEDICARE/MEDICAID TRADE (DOMESTIC/FOREIGN) TAXATION/INTERNAL REVENUE CODE BUDGET/APPROPRIATIONS COPYRIGHT/PATENT/TRADEMARK

Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA

Medicare Part D Coverage Gap

US-Japan Trade Agreement

Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act of 2017 (TCJA)

2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018

Creates Act Transferable exclusivity

Lobbyists:

Foreign Entities:

Foreign Entity Name:
CACIF
Country :
GUATEMALA
Contribution :
$30,000

Lobbying on the following issues:

MEDICARE/MEDICAID COPYRIGHT/PATENT/TRADEMARK TAXATION/INTERNAL REVENUE CODE TRADE (DOMESTIC/FOREIGN) HEALTH ISSUES

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency

Creates Act

Comprehensive Corporate Tax Reform International Tax Reform Digital Services Tax

U.S.- Japan Trade Negotiations China Trade Negotiations NAFTA/USMCA

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform

Lobbyists:

RIEMER, ANGELA Walker
WALTON, JENNIFER ANNE
Schellhas, CAROLINE Moody
BURG, PAULA
JONES, ROBERT
MUELLER, EMILY
ROBINSON, CATHERINE
ALBEN, ELISSA

Foreign Entities:

Foreign Entity Name:
AES-3C Maritza East
Country :
BULGARIA
Contribution :
$3,953

Money Spent:

Amount	Client	Government Entities

$4,200,000

Apr 22, 2019

FIRST QUARTER REPORT

Pfizer Inc.

White House Office
Commerce, Dept of (DOC)
Office of Management & Budget (OMB)
State, Dept of (DOS)
Health & Human Services, Dept of (HHS)
Treasury, Dept of
Office of the Vice President of the United States
Centers For Medicare and Medicaid Services (CMS)
U.S. Trade Representative (USTR)
SENATE
Natl Economic Council (NEC)
HOUSE OF REPRESENTATIVES
Executive Office of the President (EOP)
Food & Drug Administration (FDA)

$4,180,000

Jul 19, 2019

FIRST QUARTER AMENDMENT

Pfizer Inc.

$4,090,000

Apr 20, 2020

FIRST QUARTER REPORT

Pfizer Inc.

$2,870,000

Jul 22, 2019

SECOND QUARTER REPORT

Pfizer Inc.

$2,830,000

Feb 1, 2019

THIRD QUARTER AMENDMENT

Pfizer Inc.

$2,300,000

Jan 31, 2020

FOURTH QUARTER AMENDMENT

Pfizer Inc.

$2,290,000

Jan 21, 2020

FOURTH QUARTER REPORT

Pfizer Inc.

$2,020,000

Apr 13, 2019

FOURTH QUARTER AMENDMENT

Pfizer Inc.

$1,980,000

Jan 22, 2019

FOURTH QUARTER REPORT

Pfizer Inc.

$1,650,000

Oct 22, 2019

THIRD QUARTER REPORT

Pfizer Inc.

ionCongress.com - United States Congressional Data